drugset / Trial / NCT02300194

Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures

NCT02300194 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Introduction: Opioids, such as morphine, act at receptors in the central nervous system, but many studies have suggested direct action peripherally on opioid receptors in sensory neurons terminals, melanocytes, keratinocytes and fibroblasts. These receptors are stimulated when occurs inflammatory processes. Hypothesis: Treatment with topical morphine 0.1% applied 30 minutes before an invasive procedure, decreases pain in children. Method: A randomised double-blind parallel study to evaluate the effect of topical application of a 0.1% morphine gel in patients undergo a procedure. 22 patients in each group will be included. Randomly assigned to either the morphine gel or a placebo hydrogel, it will be applied 30 minutes before the procedure and the first day every 4 hours. General basic sedation and systemic analgesia will give for all the patients. Efficacy of treatment will be measured with "Face, Legs, Activity, Cry, Consolability scale" (FLACC scale).

Timeline

Start
2014-12
Primary completion
2020-04
Completion
2020-04

Outcome

Outcome not reported

Stopped: “Withdrawn by investigators”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 0.1 % Topical

Indications

No indication recorded.